WithdrawnPhase 3

Pilocarpine After Combined Cataract/Trabectome Surgery

Stopped: not performing Trabectomes

United States0Started 2019-06-05

Plain-language summary

Combined cataract + trabectome surgery is a surgery designed to help lower the intraocular pressure (pressure in the eye) and hopefully reduce the need for topical drops, progression of glaucoma, and/or further glaucoma surgeries. The purpose of this study is to assess whether using pilocarpine, a medication which is FDA approved to induce miosis, (in other words cause the pupil to constrict or become smaller) provides additional benefit to the success of Trabectome and cataract surgery.

Who can participate

Age range30 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age Range: 30 to 100 years old * Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with trabectome in a single surgical center Exclusion Criteria: * Patients with previous history of eye surgeries (including laser procedures).

What they're measuring

Percentage of intraocular lowering from baseline

Timeframe: Up to 1 year

Number of IOP lowering agents required to achieve goal IOP

Timeframe: Up to 3 years

Rate of progression to further glaucoma surgeries.

Timeframe: Up to 3 years

Trial details

NCT IDNCT04005079

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-01-21

View on ClinicalTrials.gov More Open Angle Glaucoma trials